The word microdosing has two separate lineages that developed independently. In regulatory pharmacology, it was defined in the early 2000s to mean a sub-pharmacological dose used in exploratory clinical trials — a technical category with nothing to do with psychedelics. In popular usage, it describes the practice of taking small amounts of psychedelics on a schedule, a meaning generally traced to James Fadiman’s 2011 handbook. The two arrived at the same word independently, a decade apart, in different communities. Knowing this history is practical, not trivial: it explains why a “microdose study” in a journal may have nothing to do with the practice most people mean.
Why this matters
When the same word carries two unrelated meanings, the history is the thing that tells them apart. The popular practice and the regulatory category were never the same idea narrowing or broadening over time — they are two separate lineages that happen to share a label. Understanding where each came from is what lets a reader recognize, on sight, which one a given source is talking about. This article traces both origins; the companion article on what “microdosing” means in research literature covers how to disambiguate them in practice. A shorter version appears in the 90-second summary on iMicrodosing.net.
Two origins, one word
- 2003 EMA position paper
The European Medicines Agency outlines conditions for single-microdose studies with reduced preclinical data.
- 2006 FDA guidance
The U.S. Food and Drug Administration codifies the exploratory IND framework, formalizing the microdose category.
- 2009 ICH harmonization
International guidance harmonizes microdose criteria across jurisdictions for drug development.
- Pre-2011 Informal experimentation
Earlier informal low-dose psychedelic experimentation existed, but without a standardized microdosing framework.
- 2011 Fadiman's handbook
”The Psychedelic Explorer’s Guide” devotes a chapter to the practice and introduces a structured schedule.
- 2015 Rising public awareness
Popular and trade media coverage expands, and the term enters mainstream conversation.
- 2019 First systematic studies
Polito and Stevenson publish an early systematic observational study; Kuypers and colleagues publish a major review.
The regulatory lineage
The older meaning is the pharmacological one. In the early 2000s, drug regulators introduced “microdose studies” as a category of exploratory human research. The European Medicines Agency’s 2003 position paper set out conditions under which a single sub-pharmacological dose could be administered with reduced preclinical safety data, [1] Government Position Paper on Non-Clinical Safety Studies to Support Clinical Trials with a Single Microdose (CPMP/SWP/2599/02) Link → and the U.S. Food and Drug Administration issued parallel guidance in 2006 establishing the same general framework. [2] Government Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies Link →
In this lineage, a microdose is defined as less than one one-hundredth of the pharmacologically active dose, capped near 100 micrograms — small enough to be sub-pharmacological while still detectable by sensitive analytical methods. [2] Government Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies Link → The purpose is to gather early pharmacokinetic data on a candidate compound before larger trials. This usage is not specific to psychedelics, not specific to any drug class, and predates the popular meaning by roughly a decade.
The popular lineage
The modern structured meaning most people now associate with psychedelic microdosing has a different and more recent history. Its entry into popular discourse is generally traced to psychologist James Fadiman’s 2011 book, which dedicated a chapter to the practice of taking small, sub-perceptual amounts of psychedelics and described a structured schedule that has since become the most widely referenced template for it. [3] Practitioner The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys Link → Fadiman did not coin a regulatory definition; he popularized a practice and gave it a name and a rhythm. (Those scheduling templates are covered in Protocols.)
Reports of people experimenting with very small amounts of psychedelics existed before the term became widely recognized. What changed in the 2010s was not necessarily the existence of low-dose experimentation, but the emergence of microdosing as a named, structured practice with schedules, self-tracking, and a shared vocabulary. Fadiman’s contribution is best understood as that of a popularizer and organizer of the practice, not the inventor of low-dose use itself.
From there the term spread through popular and trade media over the following years, well ahead of the research. By the time the first systematic studies appeared at the end of the 2010s, the popular usage was already established. A 2019 review in the Journal of Psychopharmacology described the practice as having “seen a rapid explosion of popularity in recent years” and explicitly noted that this popular meaning is distinct from the regulatory definition that preceded it. [4] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
Why the divergence persists
The two meanings have not merged, and there is no particular reason to expect them to. They live in different literatures, describe different dose categories, and answer different questions. The regulatory term is a fixed technical category; the popular term continues to evolve and has no formally agreed definition. [5] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023 Some authors use sub-perceptual dosing or low-dose psychedelic use specifically to avoid the collision, but no single replacement has standardized. [5] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023
The practical residue of this history is that the word alone is ambiguous. The origin of each meaning — regulatory drug development on one side, a 2011 popular handbook on the other — is the most reliable way to keep them apart.
Why definitions shape evidence
Scientific conclusions depend on what intervention is actually being studied. A regulatory microdose designed to measure pharmacokinetics and a psychedelic microdosing practice built around repeated sub-perceptual exposure answer entirely different research questions. Confusing the two can lead readers to transfer evidence from one field into another where it does not apply — citing a Phase 0 pharmacokinetic study as if it spoke to mood or cognition, or vice versa. The regulatory framework is detailed further in the research-literature companion, and the broader receptor pharmacology in How It Works; the point here is that the definition you adopt silently determines which evidence is even relevant.
- Regulatory microdose
- A sub-pharmacological dose used in exploratory clinical trials, defined by the FDA and EMA in the early 2000s for drug development. [2] Government Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies Link →
- Popular microdose
- A sub-perceptual amount of a psychedelic taken on a schedule, a usage popularized by Fadiman’s 2011 handbook. [3] Practitioner The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys Link →
- Independent convergence
- The two meanings did not branch from a common root; they developed separately and arrived at the same word a decade apart. [4] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
Frequently asked questions
Did James Fadiman invent microdosing?
He did not invent the underlying practice, but his 2011 handbook is generally credited with popularizing the term and introducing the structured schedule most commonly referenced today. The word’s entry into mainstream usage is traced to that work. [3] Practitioner The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys Link →
Which meaning of microdosing came first?
The regulatory pharmacology meaning is older, formalized through FDA and EMA guidance in 2003-2006. The popular psychedelic usage is generally dated to 2011, roughly a decade later. [1] Government Position Paper on Non-Clinical Safety Studies to Support Clinical Trials with a Single Microdose (CPMP/SWP/2599/02) Link → [2] Government Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies Link →
Are the two meanings related at all?
Only by the shared word. They developed in different communities, describe different dose categories, and inhabit separate research literatures. A peer-reviewed review explicitly notes that the popular usage is distinct from the regulatory definition. [4] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
Is there a less ambiguous term for the popular practice?
Some authors use sub-perceptual dosing or low-dose psychedelic use to avoid confusion with the regulatory meaning, but none of these alternatives has standardized across the field. [5] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023
Was microdosing practiced before the word became popular?
Yes. Informal reports of taking very small psychedelic amounts existed before the modern term became common. The major change after 2011 was the organization of the practice around the word microdosing, structured schedules, and systematic self-reporting. [3] Practitioner The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys Link →
In summary
The term microdosing carries two unrelated meanings that arose independently. The regulatory one, defined by the FDA and EMA in the early 2000s, refers to a sub-pharmacological dose used in exploratory drug trials. The popular one, traced to James Fadiman’s 2011 handbook, refers to a scheduled practice of taking sub-perceptual amounts of psychedelics. The two never converged from a shared origin; they reached the same word a decade apart, in different fields, and remain distinct. That history is the most dependable tool for telling which meaning any given source intends.